Skip to main content

Advertisement

Log in

Renal involvement in adrenal insufficiency (Addison disease): can we always recognize it?

  • IM - REVIEW
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

Addison disease is due to the destruction or dysfunction of the entire adrenal cortex. Nowadays, the causes of adrenal insufficiency are autoimmune disease for 70–90% and tuberculosis for 7–20%. Many typical signs and symptoms, such as hyponatremia, hyperkalaemia, or renal insufficiency can represent the reasons for a nephrology consultation, especially in conditions of urgency, and they can easily be confused with other causes. Moreover, the fact that in a short time range we have diagnosed the three cases described as a guide in this review, has aroused our attention as nephrologists on a disease in which we have probably already encountered but without recognizing it. The blood tests showed in all three patients severe electrolyte disorders and acute renal failure which will be discussed in their physiopathogenetic mechanisms. In a peculiar way, these alterations were not controlled with repolarizing solutions, fluid replacement and increased volemia, but only after steroid administration. In conclusion, in this review all the known pathogenic mechanisms causing disorders of nephrological interest in adrenal insufficiency are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Addison T (1855) On the constitutional and local effects of disease of the suprarenal capsules. Highley, London

    Google Scholar 

  2. Irvine WJ, Barnes EW (1972) Adrenocortical insufficiency. Clin Endocrinol Metab 1:549

    Google Scholar 

  3. Zelissen PM, Bast EJ, Croughs RJ (1995) Associated autoimmunity in Addison's disease. J Autoimmun 8:121–130

    CAS  PubMed  Google Scholar 

  4. Kasperlik-Zaluska AA, Migdalska B, Czarnocka B et al (1991) Association of Addison's disease with autoimmune disorders—a long-term observation of 180 patients. Postgrad Med J 67:984–987

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Moreira AC, Martinez R, Castro M, Elias LL (1992) Adrenocortical dysfunction in paracoccidioidomycosis: comparison between plasma beta-lipotrophin/adrenocorticotrophin levels and adrenocortical tests. Clin Endocrinol 36:545–551

    CAS  Google Scholar 

  6. Nomura K, Demura H, Saruta T (1994) Addison's disease in Japan: characteristics and changes revealed in a nationwide survey. Intern Med 33:602–606

    CAS  PubMed  Google Scholar 

  7. Willis AC, Vince FP (1997) The prevalence of Addison's disease in Coventry, UK. Postgrad Med J 73:286–288

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Laureti S, Vecchi L, Santeusanio F, Falorni A (1999) Is the prevalence of Addison's disease underestimated? J Clin Endocrinol Metab 84:1762

    CAS  PubMed  Google Scholar 

  9. Erichsen MM, Lovas K, Skinnisqrud B et al (2009) Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab 94:4882–4890

    CAS  PubMed  Google Scholar 

  10. Cutolo M (2014) Autoimmune polyendocrine syndrome Auitoimmun Rev 13:85–89

    CAS  Google Scholar 

  11. Brandao Neto RA, De Carvalho JF (2014) Diagnosis and classification of Addison’s disease (autoimmune adrenalitis). Autoimmun Rev 13:408–411

    CAS  PubMed  Google Scholar 

  12. Olafsson AS, Sigurjonsdottir HA (2016) Increasing prevalence of Addoson disease: results from a nationwidw study. Endocr Pract 22:30–35

    PubMed  Google Scholar 

  13. Betterle C, Dal Pra C, Mantero F, Zanchetta R (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndrome: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23:327–364

    CAS  PubMed  Google Scholar 

  14. Lombardi M, Michelassi S, Betterle C (2013) Conoscerlo per riconoscerlo: morbo di Addison con sindrome poliendocrina autoimmune di tipo II. Giornale di Tecniche Nefrologiche e Dialitiche 25:37–42

    Google Scholar 

  15. Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, Johannsson G (2006) Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 91:4849–4853

    CAS  PubMed  Google Scholar 

  16. Muls E, Bouillon R, Boelaert J et al (1982) Etiology of hypercalcemia in a patient with Addison’s desease. Calcif Tissue Int 34:523–526

    CAS  PubMed  Google Scholar 

  17. Arlt W, Allolio B (2003) Adrenal insufficiency. Lancet 361:1881–1893

    CAS  PubMed  Google Scholar 

  18. Bornstein SR, Allolio B, Arlt W et al (2016) Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101:364–389

    CAS  PubMed  Google Scholar 

  19. Lau SY, Yong TY (2012) Rhabdomyolysis in acute primary adrenal insufficiency complicated by severe hyponatremia. Intern Med 51:2371–2374

    PubMed  Google Scholar 

  20. Maguet H, Carreau A, Hautefeuille S et al (2017) An Addison disease revealed with a serious hyponatremia. Ann Biol Clin 75:87–91

    Google Scholar 

  21. Oelkers W (1989) Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N Engl J Med 321:492–496

    CAS  PubMed  Google Scholar 

  22. Ishikawa S, Schrier RW (1982) Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats. Kidney Int 22:587–593

    CAS  PubMed  Google Scholar 

  23. Kamoi K, Tamura T, Tanaka K et al (1993) Hyponatremia and osmoregulation of thirst and vasopressin secretion in patients with adrenal insufficiency. J Clin Endocrinol Metab 77:1584–1588

    CAS  PubMed  Google Scholar 

  24. Smith JP, Burren C, Cherinet Y (2011) Extreme hyponatremia with intact neurological outcome in a young child with Addison’s disease. BMJ Case Rep. https://mc.manuscriptcentral.com/bmjcasereports10.1136/bcr.07.2011.4561.10.1136/bcr.07.2011.4561

  25. Correia F, Fernandes A, Mota TC et al (2015) Hyponatremia in a teenager: a rare diagnosis. Pediatr Emerg Care 31:860–863

    PubMed  Google Scholar 

  26. Waise A, Young RJ (1989) Pitfalls in the management of acute adrenocortical insufficiency: discussion paper. J R Soc Med 82:741–742

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Connor A, Care S, Taylor J (2010) Addison’s disease presenting with acute kidney injury. Clin Med 10:15–16

    Google Scholar 

  28. Thompson MD, Kalmar E, Bowden SA (2015) Severe hyponatremia with absence of hyperkalaemia in rapidly progressive Addison’s disease. BMJ Case Rep. doi: https://mc.manuscriptcentral.com/bmjcasereports10.1136/bcr-2015–209903

  29. Fraser R (1984) Disorders of the adrenal cortex: their effects on electrolyte metabolism. Clin Endocrinol Metab 13:413–430

    CAS  PubMed  Google Scholar 

  30. Talbott JH, Pecora LJ, Melville RS, Consolazio WV (1942) Renal function in patients with Addison’s disease and in patients with adrenal insufficiency secondary to pituitary pan-hypofunction. J Clin Invest 21:107–119

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Harvey TC (2007) Addison’s disease and the regulation of potassium: the role of insulin and aldosterone. Med Hypotheses 69:1120–1126

    CAS  PubMed  Google Scholar 

  32. Maki S, Kramarz C, Heister MP, Pasha K. (2016) First presentation of Addison’s disease as hyperkalemia in acute kidney injury. BMJ Case Rep. doi: https://mc.manuscriptcentral.com/bmjcasereports10.1136/bcr-2015-213375

  33. Siengler DI (1970) Idiopatic Addison’s disease presenting with hypercalcemia. Br Med J 2:522

    Google Scholar 

  34. Diamond T, Thornley S (1994) Addisonian crisis and hypercalcemia. Aust N Z J med 24:316

    CAS  PubMed  Google Scholar 

  35. Montoli A, Colussi G, Minetti L (1992) Hypercalcemia in Addison’s disease: calciotropic hormone profile and bone hystology. J Intern Med 232:535–540

    CAS  PubMed  Google Scholar 

  36. Miell J, Wassif W, McGregor A et al (1991) Life-threatening hypercalcaemia in association with Addisonian crisis. Postgrad Med J 67:770–772

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Yamamoto S, Okada Y, Arao T, Tanaka Y (2015) Secondary adrenocortical insufficiency complicated by marked hypercalcemia and eosinophilia: a case report. J UOEH 37:55–60

    CAS  PubMed  Google Scholar 

  38. Walser M, Robinson BH, Duckett JW (1963) The hypercalcemia of adrenal insufficiency. J Clin Inv 42:456–465

    CAS  Google Scholar 

  39. Guleke P (1911) Experimentelle untersuchungen uber tetanic. Langenbecks Arch Klin Chir 94:496

    Google Scholar 

  40. Loeb RF (1932) Chemical changes in the blood in Addison’s disease. Science 76:420

    CAS  PubMed  Google Scholar 

  41. Downie WW, Gunn A, Paterson CR, Howie GF (1977) Hypercalcemic crisis as presentation of Addison’s disease. Br Med J 1:145–146

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Quinkler M, Ekman B, Zhang P (2018) EU-AIR Investigators. Mortality data from the European Adrenal Insufficiency Registry – Patient characterization and associations. Clin Endocr 89:30–35

    CAS  PubMed  Google Scholar 

  43. Iwasaku M, Shinzawa M, Tanaka S et al (2017) BMC Endocrine disorders 17:58

    PubMed  PubMed Central  Google Scholar 

  44. Anglin RE, Rosebush PI, Mazurek MF (2006) The neuropsychiatric profile of Addison’s disease: revisiting a forgotten phenomenon. J Neuropsychiatry Clin Neurosci 18:450–459

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Claudia Fofi.

Ethics declarations

Conflicts of interest

This manuscript has not been published and is not under consideration for publication elsewhere. All authors have no conflicts of interest to disclose.

Statement of human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fofi, C., Maresca, B., Altieri, S. et al. Renal involvement in adrenal insufficiency (Addison disease): can we always recognize it?. Intern Emerg Med 15, 23–31 (2020). https://doi.org/10.1007/s11739-019-02209-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-019-02209-x

Keywords

Navigation